Newsletter | November 12, 2025

11.12.25 -- Redefining API Manufacturing Through Continuous Innovation

Liquid Phase Peptide Synthesis: Regulatory, Analytical, And QC Perspectives

Discover how Liquid Phase Peptide Synthesis (LPPS) is transforming traditional peptide manufacturing by combining batch and continuous flow technologies for greater efficiency and sustainability. Explore key insights that ensure product integrity and accelerate development.

 

Continuous Manufacturing: An Evolving Technology For Drug Manufacturing

Continuous chemical manufacturing technology has been in use for more than 100 years, producing high-volume commodity chemicals. Uncover exciting developments in the field and how leveraging this technology can improve manufacturing processes.

 

Enabling Complexity: Drug Substance Manufacturing Via Continuous Flow

As drug substance molecular complexity continues to increase, flow chemistry is becoming an essential enabling technology as it facilitates the integration of complex synthetic methods into clinical and commercial production of Active Pharmaceutical Ingredients (APIs).

 

Adapting To Change – API Custom Development And Manufacturing

See what happened when a top 100 European-based pharmaceutical company sought a partner to assist with development work and scale-up to commercial manufacturing for a molecule in clinical Phase 2/3 trials, where the chemistry required was particularly challenging.

 

SOLUTIONS

Your Molecule. Our Mission.

Our scientists excel at building connections. Start a conversation today and discover the benefits of partnering with a collaborative CDMO.

• Request Information